Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/US CTAD Task Force

Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and logistical challenges to th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of Prevention of Alzheimer's Disease 2019-01, Vol.6 (3), p.164-168
Hauptverfasser:	Gauthier, Serge, Alam, J., Fillit, H., Iwatsubo, T., Liu-Seifert, H., Sabbagh, M., Salloway, S., Sampaio, C., Sims, J. R., Sperling, B., Sperling, R., Welsh-Bohmer, K. A., Touchon, J., Vellas, B., Aisen, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	CTAD Task Force Paper Geriatrics/Gerontology Life Sciences Medicine Medicine & Public Health Neurology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!